dihexa c-met cancer risk

dihexa c-met cancer risk The role of MET in chemotherapy resistance Dihexa UK: Evidence-Based Peptide Research

Name: dihexa c-met cancer risk The role of MET in chemotherapy resistance Dihexa UK: Evidence-Based Peptide Research
Brand: webdevsolutions.tech
SKU: 94948274498
Price: 25.01 USD
Availability: InStock
Rating: 4.594 (12 reviews)

Dihexa UK: Evidence Based Peptide Research Guide Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Targeting c MET in gastrointestinal tumours: rationale, opportunities and challenges Nature Reviews Clinical Oncology dihexa cancer risk hgf c met Unveiling the Role of HGF c Met Signaling in Non Small Cell Lung Tumor Microenvironment dihexa hgf c met agonist Anti cancer

SKU: 94948274498 · From webdevsolutions.tech

4.6

USD25.01 USD67.01

Pay in 4 interest-free payments of $6.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

doi: 10.1056/NEJMp2300938 292

Healing efficiency increases through sustained vascular support

Concentration: 10MG/ML Total Volume: 30ML Total Content: 300MG Format: cGMP liquid research prep Compound: Dihexa Available Format 1: 5MG per capsule 60 capsules cGMP finished capsule product Available Format 2: 10MG/ML 30ML cGMP liquid research prep Total Content Per Format: 300MG Dihexa Research Category: Neurotrophic / HGF c-Met pathway research Research Focus: HGF/c-Met signaling, synaptogenic pathway models, neurotrophic signaling, neuronal connectivity, dendritic spine biology, cognitive pathway research, and CNS cellular response systems